Skip to main content
    D

    DexCom Inc (DXCM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $81.61
    -1.72 (-2.06%)

    Market Cap: $31.08B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    DexCom Inc (DXCM) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to DexCom are GE HealthCare Technologies (GEHC), Zimmer Biomet Holdings (ZBH) and Koninklijke Philips NV ADR (PHG). DexCom trades at 30.6x earnings, against a median of 19.4x for the 8 of these companies with a P/E. By market cap, DexCom ranks 4th of the 13 companies on this page; Boston Scientific (BSX) is the largest at $64.27B.

    Peer Comparison

    DXCM's ROIC of 26.2% is above the peer median of 7.5%, and its revenue growth of 11.2% is above the median of 8.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    DexCom (DXCM)$31.08B30.6x6.0x19.4%26.2%11.2%0.00%
    GE HealthCare Technologies Inc. (GEHC)$37.54B16.9x1.7x9.9%11.9%7.2%0.19%
    Zimmer Biomet Holdings Inc (ZBH)$19.53B12.0x2.3x8.9%5.0%3.1%0.95%
    Koninklijke Philips NV ADR (PHG)$29.66BN/A1.5x5.4%7.2%2.1%3.34%
    STERIS plc (STE)$25.67B24.1x4.1x13.4%9.4%8.8%1.05%
    Edwards Lifesciences Corp (EW)$61.61B36.4x9.2x15.3%7.5%10.5%0.00%
    Boston Scientific Corp (BSX)$64.27B13.7x3.0x16.6%10.2%1.4%0.00%
    Insulet Corporation (PODD)$10.58B21.9x3.2x13.4%18.1%19.2%0.00%
    Penumbra Inc (PEN)$12.65B77.4x8.1x10.1%N/A15.6%0.00%
    Globus Medical (GMED)$9.57B14.2x3.0x17.8%N/A-0.7%0.00%
    10X Genomics Inc (TXG)$7.65BN/A11.6x-10.8%N/A1.1%0.00%
    Tandem Diabetes Care Inc (TNDM)$1.40BN/A1.2x-4.6%-3.4%13.8%0.00%
    Senseonics Holdings, Inc. Common Stock (SENS)$579.58MN/A11.9x-204.2%-71.4%141.6%0.00%
    Peer median$16.09B19.4x3.1x10.0%7.5%8.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to DexCom, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    GE HealthCare Technologies Inc. (GEHC)
    GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States.
    GEHC competitors
    Zimmer Biomet Holdings Inc (ZBH)
    Zimmer Biomet is a publicly traded medical device company.
    ZBH competitors
    Koninklijke Philips NV ADR (PHG)
    Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally.
    PHG competitors
    STERIS plc (STE)
    Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system.
    STE competitors
    Edwards Lifesciences Corp (EW)
    Edwards Lifesciences is an American medical technology company headquartered in Irvine, California...
    EW competitors
    Boston Scientific Corp (BSX)
    Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties...
    BSX competitors
    Insulet Corporation (PODD)
    Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
    PODD competitors
    Penumbra Inc (PEN)
    Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally.
    PEN competitors
    Globus Medical (GMED)
    Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders.
    GMED competitors
    10X Genomics Inc (TXG)
    10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables...
    TXG competitors
    Tandem Diabetes Care Inc (TNDM)
    Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United...
    TNDM competitors
    Senseonics Holdings, Inc. Common Stock (SENS)
    Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United...
    SENS competitors

    Frequently Asked Questions About DXCM

    Who are DexCom's main competitors?

    The companies most similar to DexCom include GE HealthCare Technologies (GEHC), Zimmer Biomet Holdings (ZBH), Koninklijke Philips NV ADR (PHG), STERIS (STE) and Edwards Lifesciences (EW), listed from the closest match.

    Who is DexCom's biggest competitor?

    Boston Scientific (BSX) is the largest of the similar companies at $64.27B; GE HealthCare Technologies (GEHC) is the closest match by business profile, size, sector and industry.

    How does DXCM stock compare with its competitors?

    DXCM's P/E is 30.6x against a peer median of 19.4x; its P/S is 6.0x against a peer median of 3.1x; its net margin is 19.4% against a peer median of 10.0%.

    Which of DexCom's competitors pays a higher dividend?

    DexCom pays no dividend. Koninklijke Philips NV ADR (PHG), STERIS (STE), Zimmer Biomet Holdings (ZBH) and GE HealthCare Technologies (GEHC) have higher forward dividend yields; Koninklijke Philips NV ADR (PHG) has the highest at 3.34%.

    Is DexCom bigger than its competitors?

    No. DexCom is 4th by market cap among the 13 companies on this page; the largest is Boston Scientific (BSX) at $64.27B.